Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice
The COVID-19 pandemic, caused by SARS-CoV-2, has rapidly spread to more than 222 countries and has put global public health at high risk. The world urgently needs cost-effective and safe SARS-CoV-2 vaccines, antiviral, and therapeutic drugs to control it. In this study, we engineered the receptor bi...
Main Authors: | Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gurbuzaslan, Burcu Gulec, Hazel Yetiskin, Muhammet Ali Uygut, Shaikh Terkis Islam Pavel, Aykut Ozdarendeli, Gulshan Mammadova, Deniz Say, Gulnara Hasanova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/8/1595 |
Similar Items
-
Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants
by: Tarlan Mamedov, et al.
Published: (2023-08-01) -
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19
by: Tarlan Mamedov, et al.
Published: (2021-11-01) -
SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants
by: Tarlan Mamedov, et al.
Published: (2023-11-01) -
Engineering, production, and immunogenicity studies of a truncated form of rabies virus glycoprotein produced in Nicotiana benthamiana plant
by: Gulshan Mammadova, et al.
Published: (2022-06-01) -
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up
by: Zafer Sezer, et al.
Published: (2024-01-01)